NCT00776113View on ClinicalTrials.gov

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

September 30, 2003

Study Completion Date

December 31, 2003

Conditions
Healthy
Interventions
DRUG

Carvedilol 12.5 mg tablets

bioequivalence Carvedilol fasting

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00776113 - Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter